Dernière mise à jour :
01/04/2025
Equipes de recherche - University Medical Center, Johannes Gutenberg   pdf  
Allemagne
Hôpital
University Medical Center, Johannes Gutenberg
Mayence
Bibliographie   Bibliographie   (40)  
1
Physicochemical I.Stability of Nab-Paclitaxel (Pazenir) Infusion Dispersions in Original Glass Vials and EVA Infusion Bags.
Linxweiler H, Thiesen J, Krämer (helen.linxweiler@unimedizin-mainz.de)
Pharmaceutics - 2024 - ; 16,1372.
2
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Linxweiler H, Thiesen J, Krämer I. (helen.linxweiler@unimedizin-mainz.de)
Pharmaceutics - 2023 - ,15, 309.
4
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening.
Almasi K, Thiesen J, Krämer I. (jannick.almasi@unimedizin-mainz.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2023 - ;8,1
5
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Almasi J, Erdnuss F, Thiesen J, Krämer I. (jannick.almasi@unimedizin-mainz.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2023 - ;8,1
6
In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes.
Knoll L, Thiesen J, Klassen .D, Reinders L.M.H, Türk J, Krämer I. (Laura. knoll@ unimedizin- mainz. de)
EJHP - 2023 -
7
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
Linxweiler H, Thiesen J, Krämer I. (helen.linxweiler@unimedizin-mainz.de)
EAHP Congress Vienna - 2022 -
8
Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes.
Mohr A, Erdnüß F, Krämer I. (andre.mohr@kgu.de)
Pharmaceutical Technology in Hospital Pharmacy - 2021 - ; 6(1): 20210005.
10
11
Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz. (KPH-AboService@Deutscher-Apotheker-Verlag.de)
Krankenhauspharmazie - 2017 - ;38,7:334?340.
12
Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen.
Kim S, Heeb R, Krämer I. (rita_marine.heeb@unimedizin-mainz.de)
Pharmaceutical Technology in Hospital Pharmacy - 2017 - ;2,4: 145-157.
14
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
Kim S.H, Thiesen J, Krämer I. (sunnyahza@naver.com)
Pharmaceutical Technology in Hospital Pharmacy - 2016 - ;1,2:73-81
15
Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
Spindeldreier K, Thiesen J, Lipp H.P, Krämer I. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 2014 - ; 20: 183-189
16
Compatibility of epirubicin-loaded DC Beads with different contrast media.
Sarakbi I, Thiesen J, Krämer I. ()
ECOP 2 Krakow - 2014 -
18
Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL.
Heeb R.M, Krämer I. (irene.kraemer@unimedizin-mainz.de)
EAHP Congress Paris - 2013 -
19
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Wollstadt A, Krämer I, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 2013 - ; 68: 744-748.
20
Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml.
Heeb R.M, Thiesen J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Krankenhauspharmazie - 2013 - ; 34, 8: 410-411.
21
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Krankenhauspharmazie - 2013 - ; 11: 524-525.
22
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 2012 - ; 18, 2: 218-221.
23
Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
EJHP Science - 2011 - ; 17, 1: 7-12.
24
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen.
Klemmer A, Krämer I. (irene.kraemer@unimedizin-mainz.de)
ADKA Congress 2011 - 2011 -
25
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Int J Pharm Compound - 2011 - ; 15, 6 : 515-520.
26
Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J, Thiesen J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 2010 - ; 16: 53-61.
27
Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Poster ADKA Congress May 2010 - 2010 -
28
Chemical and physical stability of diluted busulfan infusion solutions.
Karstens A, Krämer I. (irene.kraemer@unimedizin-mainz.de)
EJHP Science - 2007 - ; 13, 2: 40-47
29
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 2007 - ; 62, 10: 760-766.
30
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Kamin W, Schwabe A, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Int J COPD - 2007 - ; 1, 4: 599-607.
31
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Krankenhauspharmazie - 2007 - ; 28, 5: 170-178.
32
Untersuchungen zur Stabilität der Busulfan-Stammlösung (Busilvex®, Busulfex TM) in B/Braun Injekt® Einmalspritzen.
Karstens A, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 2006 - ; 10: 845-850.
33
Characterization of an extemporaneous liquid formulation of lisinopril
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL. ()
Am J Health-Syst Pharm - 2003 - ; 60: 69-74.
34
Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags.
Thiesen J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 2000 - ; 6, 3: 115-121.
35
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Thiesen J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharm World Sci - 1999 - ; 21: 137-141.
36
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices.
Krämer I, Thiesen J. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 1999 - ; 5: 75-82.
37
Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Sattler A, Jage J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 1998 - ; 53: 386-391.
38
Stability of meropenem in elastomeric portable infusion devices.
Krämer I. (irene.kraemer@unimedizin-mainz.de)
Eur Hosp Pharm - 1997 - ; 3: 168-171.
39
Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J. (irene.kraemer@unimedizin-mainz.de)
TAP Pharmazeutische Zeitung - 1997 - ; 31: 30-33.
40
Stabilität von bendamustinhydrochloride in infusion lösungen.
Maas B, Huber C, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 1994 - ; 49, 10: 775-777.

Liste des molécules   Molécules étudiées   (39)  

  Mentions Légales
BESbswy